A quick look at some screening data in 3 close European countries demonstrates how research subjects travel to screen concurrently at multiple different sites. Professional research subjects often travel large distances between states or countries to do so. Some travel is within the same country to different sites, but there is significant travel between countries. …
We have seen tremendous progress within the clinical trials research industry in understanding the scope of the issue with duplicate subjects in clinical trials or professional research subjects over the past few years. Verified Clinical Trials (VCT) provides an easy to implement cost-savings approach to prevent duplicate subjects and other important protocol violations in your …
Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany. The meeting will include many of our current and future users of the VCT research subject database registry to prevent duplicate subjects in clinical trials and as well as other protocol violations. The workshop …
Verified Clinical Trials (VCT) is the global research subject database registry utilized across all phases of clinical trials research to prevent duplicate subjects and other key protocol violations. Data shows that a research subject registry will detect and prevent duplicate subjects and other protocol violations. Up to 10% in CNS clinical trials and much higher …
Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …
Verified Clinical Trials (VCT) the leading global research subject database registry has teamed up with the STARR Coalition to create Project RockSTARR. The initiative allows sponsors to have research subjects that screen for a clinical trial donate a pre-allocated amount of money to local advocacy group of their choice. Advocacy and duplicate subject prevention in …
Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …
From phase 1 through phase 4 drug development, the issue of duplicate subjects in clinical trials exists. Verified Clinical Trials (VCT). www.verifiedclinicaltrials.com is here to prevent these issues and promote safety and data quality. Duplicate subjects in CNS clinical trials is especially needed, but VCT protects most therapeutic areas. Characteristics of duplicate subjects are not …
Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data …
Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data. The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening. What we have learned from experience and analytical data review over the …
